DiscoverGlobal HIV Vaccine Enterprise AIDS Vaccine 2013 ConferenceRoundtable Discussion: Clinical Trial Follow-up and Retention
Roundtable Discussion: Clinical Trial Follow-up and Retention

Roundtable Discussion: Clinical Trial Follow-up and Retention

Update: 2020-09-15
Share

Description

Roundtable Discussion: Clinical Trial Follow-up and Retention
"Phase 2b Trial of the VRC's DNA/rAd5 Vaccine Regimen in Circumcised, Ad5 Neut Ab(-) Persons in the United States" by Scott Hammer Columbia University Medical Center, New York, NY, United States of America

Comments 
In Channel
Roundtable Discussion: Clinical Trial Follow-up and Retention

Roundtable Discussion: Clinical Trial Follow-up and Retention

2020-09-15--:--

Roundtable Discussion: Clinical Trial Follow-up and Retention

Roundtable Discussion: Clinical Trial Follow-up and Retention

2020-09-15--:--

Roundtable Discussion: Clinical Trial Follow-up and Retention

Roundtable Discussion: Clinical Trial Follow-up and Retention

2020-09-15--:--

Roundtable Discussion: Clinical Trial Follow-up and Retention

Roundtable Discussion: Clinical Trial Follow-up and Retention

2020-09-15--:--

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

2020-09-15--:--

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

2020-09-15--:--

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

2020-09-15--:--

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

2020-09-15--:--

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

2020-09-15--:--

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

Scripps CHAVI-ID Satellite Session: Structure and Antigenicity of Soluble, Cleaved (SOSIP) HIV-1 gp140 Trimers

2020-09-15--:--

Closing Session

Closing Session

2020-09-15--:--

Closing Session

Closing Session

2020-09-15--:--

Closing Session

Closing Session

2020-09-15--:--

Closing Session

Closing Session

2020-09-15--:--

Plenary 04: Emerging Clinical Trial Data

Plenary 04: Emerging Clinical Trial Data

2020-09-15--:--

Plenary 04: Emerging Clinical Trial Data

Plenary 04: Emerging Clinical Trial Data

2020-09-15--:--

Plenary 04: Emerging Clinical Trial Data

Plenary 04: Emerging Clinical Trial Data

2020-09-15--:--

Plenary 04: Emerging Clinical Trial Data

Plenary 04: Emerging Clinical Trial Data

2020-09-15--:--

Plenary 04: Emerging Clinical Trial Data

Plenary 04: Emerging Clinical Trial Data

2020-09-15--:--

Plenary 03: Innovations in HIV Vaccine Discovery

Plenary 03: Innovations in HIV Vaccine Discovery

2020-09-15--:--

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Roundtable Discussion: Clinical Trial Follow-up and Retention

Roundtable Discussion: Clinical Trial Follow-up and Retention

Global HIV Vaccine Enterprise